Fennec Pharmaceuticals (NASDAQ: FENC) reported Q2 EPS of ($0.20), $0.18 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $7.3 million versus the consensus estimate of $11.05 million.

For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.